Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
48,932,355
-
Total 13F shares
-
21,590,557
-
Share change
-
+2,530,605
-
Total reported value
-
$826,608,565
-
Put/Call ratio
-
102%
-
Price per share
-
$38.30
-
Number of holders
-
164
-
Value change
-
+$90,967,881
-
Number of buys
-
87
-
Number of sells
-
64
Institutional Holders of Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) as of Q2 2022
As of 30 Jun 2022 Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) had 164 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 21,590,557 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., RTW INVESTMENTS, LP, PFM Health Sciences, LP, Fairmount Funds Management LLC, STATE STREET CORP, Bellevue Group AG, ALETHEA CAPITAL MANAGEMENT, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., and Nuveen Asset Management, LLC.
This table shows 164 institutional shareholders of the security as of 30 Jun 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.